Shockwave Medical is clearing the way for Johnson & Johnson MedTech to retake its title as the world's largest medical device ...

The firm will continue developing Lava's two partnered bispecific gamma delta T-cell engager programs with Pfizer and Johnson & Johnson.

Shockwave Medical CMO Dr. Nick West discusses the intravascular lithotripsy developer's plans for next-gen devices and new ...

Johnson & Johnson (NYSE: JNJ) is one of the top cheap pharmaceutical stocks to buy now. On July 29, Johnson & Johnson ...

Wall Street trading got off to a positive start on Monday as major indices tried to rebound from Friday's heavy losses.

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Advisors XOMA Royalty was represented by Gibson, Dunn & Crutcher LLP and Loyens & Loeff N.V, who acted as U.S. and Dutch legal advisors, respectively. Leerink Partners is acting as exclusive financial ...

Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts ...

CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.

Johnson & Johnson is a globally diversified healthcare conglomerate with two main operating segments. The Innovative Medicine ...

To mark World Lung Cancer Day, Johnson & Johnson (J&J) has launched “The 3rd opinion” across Asia Pacific. A campaign that aims to empower patients to play a more active role in their treatment ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.